Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples